Table 4.

Longitudinal survey of seven patients with active SLE

Patient	Time*	ANA (dilution)	Anti-dsDNA antibody (IU/ml)	CH50 (%)	CD8+DR+ cells (%)
106	− 2	4000	359	45	10·60
	− 1	4000	380	35	13·50
	Flare	4000	459	27	23·36
	+ 2	1000	35	80	13·66
	+ 4	500	21	120	13·06
110	− 6	8000	10	66	14·02
	− 3	16000	45	ND†	16·06
	Flare	32000	121	67	18·78
	+ 3	8000	15	70	12·90
111	− 5	32000	75	65	9·36
	Flare	32000	60	90	14·86
	+ 2	16000	45	80	13·12
	+ 5	32000	166	80	6·30
113	− 6	250	0	96	10·98
	− 2	250	0	82	15·28
	Flare	250	0	80	17·12
	+ 3	250	0	92	10·62
114	− 6	500	0	124	11·39
	− 2	500	0	80	18·56
	Flare	500	0	70	17·92
	+ 6	100	0	88	10·84
117	− 3	2000	60	100	9·84
	Flare	2000	37	75	17·28
	+ 4	1000	58	75	13·96
121	− 9	16000	78	65	10·27
	− 2	8000	85	78	12·36
	Flare	8000	32	65	19·20
	+ 5	16000	37	86	17·30

^*Time points are expressed in month(s) before flare (− number) and after flare (+ number).

^†Not determined. For other abbreviations, see text.